Back to Search
Start Over
Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma
- Source :
- PLoS ONE, Vol 9, Iss 9, p e108414 (2014), PLoS ONE, e108414
- Publication Year :
- 2014
- Publisher :
- Public Library of Science, 2014.
-
Abstract
- There are currently no established radiological parameters that predict response to immunotherapy. We hypothesised that multiparametric, longitudinal magnetic resonance imaging (MRI) of physiological parameters and pharmacokinetic models might detect early biological responses to immunotherapy for glioblastoma targeting NG2/CSPG4 with mAb9.2.27 combined with natural killer (NK) cells. Contrast enhanced conventional T1-weighted MRI at 761 and 1762 days posttreatment failed to detect differences in tumour size between the treatment groups, whereas, follow-up scans at 3 months demonstrated diminished signal intensity and tumour volume in the surviving NK+mAb9.2.27 treated animals. Notably, interstitial volume fraction (ve), was significantly increased in the NK+mAb9.2.27 combination therapy group compared mAb9.2.27 and NK cell monotherapy groups (p = 0.002 and p = 0.017 respectively) in cohort 1 animals treated with 1 million NK cells. ve was reproducibly increased in the combination NK+mAb9.2.27 compared to NK cell monotherapy in cohort 2 treated with increased dose of 2 million NK cells (p,0.0001), indicating greater cell death induced by NK+mAb9.2.27 treatment. The interstitial volume fraction in the NK monotherapy group was significantly reduced compared to mAb9.2.27 monotherapy (p,0.0001) and untreated controls (p = 0.014) in the cohort 2 animals. NK cells in monotherapy were unable to kill the U87MG cells that highly expressed class I human leucocyte antigens, and diminished stress ligands for activating receptors. A significant association between apparent diffusion coefficient (ADC) of water and ve in combination NK+ mAb9.2.27 and NK monotherapy treated tumours was evident, where increased ADC corresponded to reduced ve in both cases. Collectively, these data support histological measures at end-stage demonstrating diminished tumour cell proliferation and pronounced apoptosis in the NK+mAb9.2.27 treated tumours compared to the other groups. In conclusion, ve was the most reliable radiological parameter for detecting response to intralesional NK cellular therapy. (c) 2014 Rygh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
- Subjects :
- Male
medicine.medical_treatment
Cancer Treatment
Gene Expression
lcsh:Medicine
Injections, Intralesional
Immunotherapy, Adoptive
Diagnostic Radiology
Diffusion
Cell therapy
Interleukin 21
Cancer immunotherapy
Neoplasms
Medicine and Health Sciences
Molecular Targeted Therapy
lcsh:Science
Neurological Tumors
Multidisciplinary
Brain Neoplasms
Radiology and Imaging
Antibodies, Monoclonal
Magnetic Resonance Imaging
Tumor Burden
Killer Cells, Natural
Neurology
Oncology
Female
Proteoglycans
Immunotherapy
Research Article
Combination therapy
Immunology
Biology
Cancer Immunotherapy
Rats, Nude
Malignant Tumors
Immune system
Antigen
Diagnostic Medicine
Cancer Detection and Diagnosis
medicine
Animals
Antigens
lcsh:R
Biology and Life Sciences
Cancers and Neoplasms
Extracellular Fluid
Image Enhancement
Rats
Disease Models, Animal
Apoptosis
Cancer research
Clinical Immunology
lcsh:Q
Glioblastoma
Glioblastoma Multiforme
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- PLoS ONE, Vol 9, Iss 9, p e108414 (2014), PLoS ONE, e108414
- Accession number :
- edsair.doi.dedup.....297726fc255593dc2ecae12f9a46ab77